Search results
Results from the WOW.Com Content Network
Advanced Bio-Treatment (ABT) is a biohazard response and remediation company operating in twenty-eight states. The company employs a multitude of cleanup teams specializing in crime scene cleanup . Day-to-day business operations are overseen by a customer service driven team from the company’s corporate office located in Jacksonville, Florida .
(Reuters) - Drugmaker Emergent BioSolutions said on Monday that it would reduce its workforce in Lansing, Michigan, by up to 70 roles as part of its ongoing restructuring efforts.
Fuad El-Hibri (deceased, April 23, 2022), the founder of the company and former CEO, [33] led the company since its founding as BioPort Inc. [34] [35] until his retirement on April 1, 2012. [36] [37] El-Hibri continued to serve as the executive chairman of Emergent BioSolutions' board of directors until shortly before his death in 2022. [38]
On June 1, 2006, the DHHS awarded a $363 million contract to Emergent BioSolutions, (then Cangene Corporation) for 200,000 doses of BAT over five years for delivery into the US Strategic National Stockpile (SNS). [10] The CDC began supplying doses to the SNS in 2007 under a now $427 million contract with the DHHS, according to a Cangene press ...
Emergent has been delivering Cyfendus to the U.S. Department of Health and Human Services since 2019, under pre-emergency use authorization status, and will continue to work with the U.S ...
1. Go to the comment you are reporting. 2. Select the Drop-Down Arrow on the far right-hand corner of the text-box. 3. Click report. If you come across an article with inappropriate or incorrect information, please let us know by submitting a feedback form.
Customer support is a range of consumer services to assist customers in making cost-effective and correct use of a product. [9] It includes assistance in planning, installation, training, troubleshooting, maintenance, upgrading, and disposal of a product. [9]
[28] [29] IMS Health shareholders received 0.384 shares of Quintiles common stock for each share of IMS Health common stock they held, leaving the split of ownership at 51.4% IMS and 48.6% Quintiles. [ 30 ] [ 31 ] The merger was completed in October and the resulting company was a $17.6 billion company called QuintilesIMS. [ 9 ]